NCT04057833View on ClinicalTrials.gov

E-CEL UVEC Cells As an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 20, 2019

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Rotator Cuff TearsMuscle Atrophy or WeaknessTendon Rupture - ShoulderSafety Issues
Interventions
DRUG

E-CEL UVEC

Local implantation of E-CEL UVEC cells at the supraspinatus tendon repair site

Trial Locations (1)

10021

Hospital for Special Surgery, New York

Sponsors

Collaborators (1)

Angiocrine Bioscience
All Listed Sponsors
collaborator

Angiocrine Bioscience

INDUSTRY

lead

Hospital for Special Surgery, New York

OTHER

NCT04057833 - E-CEL UVEC Cells As an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults | Biotech Hunter | Biotech Hunter